Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00051_DB08895_nanopub.RAmQQoDa_Jv_Foi8CDdMh8qtc0PBVQ3RHa3tbALH8Pdkc#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00051_DB08895 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00051_DB08895 label "DDI between Adalimumab and Tofacitinib - Adalimumab (and other anti-TNF immunosuppressants), when used in combination with tofacitinib, may increase the risk of added immunosuppression. It is recommended to avoid concurrent therapy. [drugbank_resource:DB00051_DB08895]" assertion.
- drugbank_resource:DB00051_DB08895 identifier "drugbank_resource:DB00051_DB08895" assertion.
- drugbank_resource:DB00051_DB08895 title "DDI between Adalimumab and Tofacitinib - Adalimumab (and other anti-TNF immunosuppressants), when used in combination with tofacitinib, may increase the risk of added immunosuppression. It is recommended to avoid concurrent therapy." assertion.
- drugbank:DB08895 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00051_DB08895 assertion.
- drugbank:DB00051 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00051_DB08895 assertion.